Zhiyuan Yao

Zhiyuan Yao

Auto-generated profile, based on publicly available information

Zhiyuan Yao

Department of Pharmacology University of North Carolina School of Medicine Chapel Hill North Carolina USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2021 in Cancer Immunology Research
Verified
Journal Article
Open access
PDF file
ELElisa Landoni
Elisa Landoni
GFGiovanni Fucá
Giovanni Fucá
JWJian Wang
Jian Wang
VCVenkat R. Chirasani
Venkat R. Chirasani
ZYZhiyuan Yao
Zhiyuan Yao
GDGianpietro Dotti
Gianpietro Dotti
Chimeric antigen receptor (CAR) tonic signaling, defined as spontaneous activation and release of proinflammatory cytokines by CAR-T cells, is considered a negative attribute because it leads to impaired antitumor effects. Here, we report that CAR tonic signaling is caused by the intrinsic instability of the mAb single-chain variable fragment (scFv) to promote self-aggregation and signaling via the CD3ζ chain incorporated into the CAR construct. This phenomenon was detected in a CAR encoding either CD28 or 4-1BB costimulatory endodomains. Instability of the scFv was caused by specific amino acids within the framework regions (FWR) that can be identified by computational modeling. Substitutions of the amino acids causing instability, or humanization of the FWRs, corrected tonic signaling of the CAR, without modifying antigen specificity, and enhanced the antitumor effects of CAR-T cells. Overall, we demonstrated that tonic signaling of CAR-T cells is determined by the molecular instability of the scFv and that computational analyses of the scFv can be implemented to correct the scFv instability in CAR-T cells with either CD28 or 4-1BB costimulation.

10 July 2026 in Protein Science
Verified
Journal Article
Closed access
ZYZhiyuan Yao
Zhiyuan Yao
MMMcGuire Metts
McGuire Metts
AHAvery K. Huber
Avery K. Huber
JLJingjing Li
Jingjing Li
TKTomoaki Kinjo
Tomoaki Kinjo
BKBrian Kuhlman
Brian Kuhlman

27 October 2025 in bioRxiv
Verified
Preprint
Open access
CSChristopher Shelby
Christopher Shelby
KKKaylee P. Kuzelka
Kaylee P. Kuzelka
JEJonathan Ellis
Jonathan Ellis
ZYZhiyuan Yao
Zhiyuan Yao
AMAmelia C. McCue
Amelia C. McCue
BKBrian Kuhlman
Brian Kuhlman
Enzyme mediated bioconjugation provides a method for easy and rapid formation of protein-protein and protein-small molecule conjugates under mild conditions. Promiscuous enzymes are of particular interest because they can catalyze conjugation reactions on a broad set of substrates. However, this promiscuity carries the risk of undesirable off-target modifications. To mitigate this effect, we used computational design to install a substrate recruitment domain (SRD) onto the promiscuous enzyme, tyrosinase. The redesigned tyrosinase, called D42, preferentially modifies tyrosine residues within the peptide core (core) linked to a 6-amino acid recognition motif/sequence (RS) specific for the SRD. Incorporation of the recognition sequence along with a neighboring tyrosine in peptides or proteins allows for rapid D42-mediated conversion of the tyrosine to an orthoquinone, which can be selectively modified with a variety of nucleophiles. We demonstrate the utility of our design system by rapidly installing cytotoxic molecules on a monoclonal antibody. For Table of Contents Only:

17 March 2026 in Bioconjugate Chemistry
Verified
Journal Article
Open access
CSChristopher Shelby
Christopher Shelby
KKKaylee P. Kuzelka
Kaylee P. Kuzelka
JEJonathan Ellis
Jonathan Ellis
ZYZhiyuan Yao
Zhiyuan Yao
AMAmelia C. McCue
Amelia C. McCue
BKBrian Kuhlman
Brian Kuhlman
Enzyme mediated bioconjugation provides a method for easy and rapid formation of protein–protein and protein-small molecule conjugates under mild conditions. Promiscuous enzymes are of particular interest because they can catalyze conjugation reactions on a broad set of substrates. However, this promiscuity carries the risk of undesirable off-target modifications. To mitigate this effect, we used computational design to install a substrate recruitment domain (SRD) onto the promiscuous enzyme, tyrosinase. The redesigned tyrosinase, called design42 (D42), preferentially modifies tyrosine residues adjacent to a 6-amino acid recognition motif/sequence (RS) that is bound by the SRD. Incorporation of the recognition sequence along with a neighboring tyrosine in peptides or proteins allows for rapid D42-mediated conversion of the tyrosine to an orthoquinone, which can be selectively modified with a variety of nucleophiles. We demonstrate the utility of our design system by rapidly installing cytotoxic molecules on a monoclonal antibody.

4 April 2023
Verified
Other
Open access
ELElisa Landoni
Elisa Landoni
GFGiovanni Fucá
Giovanni Fucá
JWJian Wang
Jian Wang
VCVenkat R. Chirasani
Venkat R. Chirasani
ZYZhiyuan Yao
Zhiyuan Yao
GDGianpietro Dotti
Gianpietro Dotti
Supplementary Figures and Legends

6 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ZYZhiyuan Yao
Zhiyuan Yao
BKBrian Kuhlman
Brian Kuhlman
The poor solubility of integral membrane proteins in water frequently hinders studies with these proteins, presenting challenges for structure determination and binding screens. For instance, the transmembrane protein CD20, which is an important target for treating B-cell malignancies, is not soluble in water and cannot be easily screened against potential protein binders with techniques like phage display or yeast display. Here, we use de novo protein design to create a water-soluble mimic of the CD20 dimer (“soluble CD20”). Soluble CD20 replaces the central transmembrane helix of CD20 with a water-soluble helix that dimerizes to form a coiled coil that structurally matches the dimer interface of native CD20 and presents the central extracellular loop of CD20 in a binding competent conformation. Unlike peptides derived from CD20, soluble CD20 binds tightly to monoclonal antibodies that recognize quaternary epitopes on the extracellular face of CD20. We demonstrate that soluble CD20 is easy to produce, remains folded above 60°C, and is compatible with binder screening via yeast display. Our results highlight the ability of computational protein design to scaffold conformational epitopes from membrane proteins for use in binding and protein engineering studies. Importance: This study demonstrates that computational protein design can be used to create water soluble variants of transmembrane proteins. The water-soluble CD20 mimic created here is compatible with high throughput binding screens and should be useful for developing next generation anti-CD20 therapeutics.